![Gallery-12.jpg](https://static.wixstatic.com/media/8937bb_37f824e96e074232847153341f7d0dee~mv2.jpg/v1/fill/w_37,h_24,al_c,q_80,usm_0.66_1.00_0.01,blur_2,enc_auto/8937bb_37f824e96e074232847153341f7d0dee~mv2.jpg)
Research Projects- CAMP
CAMP
CAMP invents and demonstrates these CQA/PAT capabilities:
-
From stem to immune cells
-
Addressing ailments ranging from cancer to tissue degeneration
-
Targeting adherent and suspended cells, with and without genetic engineering
-
Leveraging deep and growing collaborations in Singapore and at MIT
Our goal is that this applied research and the new workforce that develops with and for the manufacturing industry & clinics will provide more patients with access to promising, approved therapies.
​
​
Flagship Project 1
Label-free critical quality attributes for personalised efficacy of cell therapies, including multivariate analysis of biological and biophysical attributes
![](https://static.wixstatic.com/media/e89dd1_ad8d9e4d1a884430acc58ff245fd4729~mv2.png/v1/fill/w_364,h_205,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/e89dd1_ad8d9e4d1a884430acc58ff245fd4729~mv2.png)
Flagship Project 2
Rapid critical quality attributes for the safety of cell sources and cell therapy products, informing process analytic technologies and speeding product release
![](https://static.wixstatic.com/media/e89dd1_3a504821ab594b41aeee21cac758cf0e~mv2.png/v1/fill/w_96,h_74,al_c,q_85,usm_0.66_1.00_0.01,blur_2,enc_auto/e89dd1_3a504821ab594b41aeee21cac758cf0e~mv2.png)
Flagship Project 3
PAT for cell proliferation and recovery, including inline and intermittent monitoring to promote efficacy and safety attributes for timely cell product release
![](https://static.wixstatic.com/media/e89dd1_b2cb44540d8648ce859b61b7108bc84a~mv2.png/v1/fill/w_122,h_54,al_c,q_85,usm_0.66_1.00_0.01,blur_2,enc_auto/e89dd1_b2cb44540d8648ce859b61b7108bc84a~mv2.png)